About Y-mabs (YMAB)
Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing the therapeutic products for the treatment of cancer. Its product pipeline includes naxitamab and omburtamab. The Compan... Read more
- USD14.92
- USD15.13
- USD14.36
- USD20.90
- -5.50%
- 85M
- 52.62k
- 364.72k
- 662M
- 4.60
- 156.70%
Stock News
2 hours ago
Align Technology, Inc. (NASDAQ:ALGN) Q1 2024 Earnings Call Transcript
Yahoo
3 hours ago
Align Technology Announces $150 Million Open Market Repurchase
Yahoo
3 hours ago
Burke & Herbert Financial Services Corp. Announces First Quarter 2024 Results and Declares Common Stock Dividend
Yahoo
3 hours ago
Imperial Oil reports higher production, lower refinery throughput in Q1
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
